Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the takeover of Credit Suisse in the context of the role of Richard Meddings as (a) a member of the board of directors and (b) chair of the risk committee at Credit Suisse.
Answered by Will Quince
No specific assessment has been made.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what role the Chair of NHS England has played in risk assessment for the NHS since his appointment.
Answered by Will Quince
The Chair of NHS England oversees the Board as the senior decision-making structure for NHS England. The Board sets the strategy and overall direction of NHS England, within the context of the National Health Service mandate from Government, overseeing delivery of the agreed strategy, the approach to risk, and establishing the culture and values of the organisation.
The Board has delegated some of its duties and responsibilities to Board Committees, which provide regular assurance to the Board on specific areas delegated to them and, by exception, escalate issues that merit full Board discussion and decision. They are led by non-executive directors and include the Audit and Risk Assurance Committee, which meets five times per year and reviews and monitors the integrity of the financial statements, financial and regulatory compliance, the systems of internal and control and the external and internal audit process. In accordance with good corporate governance, the Chair of NHS England is not a Member of the Audit and Risk Assurance Committee.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will carry out a review of the necessary and desirable qualifications for the role of Chair of NHS England.
Answered by Will Quince
We have no specific plans to carry out such a review.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will undertake an independent review of the 2017 Expert Working Group Report on Primodos.
Answered by Caroline Johnson
We have no plans to do so.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what contingency plans his Department has in place to ensure that the NHS has access to sodium hypochlorite in the event that the shortage being experienced continues.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department and the National Health Service have not received any such reports of insufficient access to sodium hypochlorite. However, the Department monitors and mitigates any disruptions to the continuity of supply of medical products.
In the event of potential disruption, the Department’s National Supply Disruption Response has been available since March 2020, supporting providers and suppliers with supply disruptions and offering express freight support 24 hours a day, seven days a week.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the NHS has sufficient access to sodium hypochlorite.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department and the National Health Service have not received any such reports of insufficient access to sodium hypochlorite. However, the Department monitors and mitigates any disruptions to the continuity of supply of medical products.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many care home residents have received a covid-19 booster vaccination who received their second covid-19 vaccination outside the care home setting.
Answered by Maggie Throup
By 14 December 2021, 99% of older persons’ homes had been visited by specialist vaccination teams to deliver the booster programme, with the remaining care homes scheduled to be visited before 24 December.
As of 12 December 2021, 251,340 residents and 114,510 staff had received a booster dose across all older adult care homes in England. By the same date, 25,974 staff and 22,727 residents of younger adult care homes had received the booster vaccination. Information on residents who received their vaccination outside the care home setting is not held centrally.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the uptake of covid-19 booster vaccines amongst people offered them in care homes; and if he will make a statement.
Answered by Maggie Throup
By 14 December 2021, 99% of older persons’ homes had been visited by specialist vaccination teams to deliver the booster programme, with the remaining care homes scheduled to be visited before 24 December.
As of 12 December 2021, 251,340 residents and 114,510 staff had received a booster dose across all older adult care homes in England. By the same date, 25,974 staff and 22,727 residents of younger adult care homes had received the booster vaccination. Information on residents who received their vaccination outside the care home setting is not held centrally.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many care homes have been visited to administer covid-19 booster vaccinations since 1 November 2021.
Answered by Maggie Throup
The information is not available in the format requested. However, the latest available data as of 14 December shows that 99% of older persons care homes have received a visit to administer booster vaccinations.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to incentivise NHS organisations to provide innovative treatments in ophthalmology.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Surgical hubs are being used to deliver high volume, low complexity operations resulting in increased number of cataract operations being performed. Trusts are increasing the use of technology to improve ophthalmic diagnostics, including the use of virtual eye hubs in which technicians administer a series of tests and consultants review results via cloud software. In some cases, hubs have halved patient journey times and reduced costs and unnecessary referrals.
NHS England and NHS Improvement are also redesigning eye-care cardiac pathways to reduce variation and improve performance across surgery, diagnostics and outpatients. The Department has provided the National Health Service with £160 million to implement and evaluate innovative ways to increase the number of elective operations they deliver through the accelerator programme. Initiatives include a high-volume cataract service and 3D eye scanners.